Pathstone Holdings, LLC Intra Cellular Therapies, Inc. Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 12,473 shares of ITCI stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,473
Previous 12,266
1.69%
Holding current value
$1.09 Million
Previous $840,000
8.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ITCI
# of Institutions
377Shares Held
85MCall Options Held
299KPut Options Held
130K-
Vanguard Group Inc Valley Forge, PA9.63MShares$844 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$554 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$463 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$337 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$267 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.27B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...